Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Chemotherapy-induced Thrombocytopenia × avatrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 5 Carcinoma, Hepatocellular 2 Lymphoma 1 Jacobs syndrome 1 Gastrointestinal Neoplasms 1 Chemotherapy-induced Thrombocytopenia 1

Interventions

oprelvekin 1 hetrombopag 1 eltrombopag 1 avatrombopag 1 Interleukin-11 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05218226 2025-02-24

Avatrombopag for Chemotherapy-induced Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting

Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡